Our Promise to You

Guaranteed product quality, expert customer support

Our Promise to You

SKG-II-SF

  • Specification
  • Recommended Products
Cat.No.
CSC-C6464J
Description
Large cell non-keratinizing squamouse carcinoma. Stage Ib. HPV type 18 integrated.
Species
Human
Tissue of Origin
cervix
Recommended Medium
Culture Properties
Adherent cells
Morphology
epithelial-like
Storage and Shipping
Ship in dry ice.
Store in liquid nitrogen.
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

For research use only. Not for any other purpose.

  • Q & A
  • Customer Review
Q:
What are the key advancements in targeted therapies for uterine/cervix tumor cells?
A:

Targeted therapies for uterine/cervix tumor cells have seen advancements in recent years. For example, the use of immune checkpoint inhibitors, such as pembrolizumab, has shown promising results in certain cases of advanced or recurrent uterine/cervix cancers. Additionally, targeted therapies that inhibit specific molecular pathways, such as inhibitors of the PI3K/AKT/mTOR pathway, are being explored in clinical trials.

Ask a Question

Average Rating: 4.0    |    1 Scientist has reviewed this product

An excellent choice

I've been using this cell product for regenerative medicine research, and it has proven to be an excellent choice. The cells displayed the desired differentiation potential and contributed to tissue repair.

10 Feb 2023


Ease of use

After sales services

Value for money


Write your own review

Customer Support & Price Inquiry

Verification Code